NCT03612791 Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab Status COMPLETED Phase PHASE2
NCT03600701 Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03598270 Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer Status COMPLETED Phase PHASE3
NCT03595592 Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03566485 Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03563716 A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT03559647 The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy Status COMPLETED Phase N/A
NCT03556839 Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix Status COMPLETED Phase PHASE3
NCT03555149 A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) Status TERMINATED Phase PHASE1/PHASE2
NCT03554083 Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma Status COMPLETED Phase PHASE2
NCT03548428 Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) Status RECRUITING Phase PHASE2
NCT03540420 Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03533283 An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03526900 Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis Status COMPLETED Phase PHASE2
NCT03526432 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03513952 Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT03502785 INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT03498716 A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer Status TERMINATED Phase PHASE3